Chemical Structure (Exemestane 01)
Exemestane Tablet, Film Coated
Product Images NDC 71921-190
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Exemestane (NDC 71921-190). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Florida Pharmaceutical Products, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Exemestane 02)
This passage reports the results of a study comparing exemestane to tamoxifen treatment in terms of disease-free survival. The study involved a total of 4724 patients who were randomly assigned to receive either exemestane or tamoxifen. Of these patients, 213 who received exemestane and 307 who received tamoxifen experienced an event. The hazard ratio (HR) was calculated as 0.69 (95% CI: 0.58-0.82), indicating a significant difference between the two treatments. The log-rank test yielded a p-value of 0.00003. The graph shows the duration of disease-free survival in months for both treatment groups.*
Figure 2 (Exemestane 03)
Image Description (Exemestane 04)
This is a description of a medication called "Exemestane". The package contains 30 tablets of 25mg each, produced by OL Pharma. The rest of the text seems to be product codes and lot information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
